CervoMed Inc. — Director's Dealing 2023

Sep 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CervoMed Inc. (CRVO)
CIK: 0001053691
Period of Report: 2023-09-15

Reporting Person: Poulton Jeffrey V. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-15	Stock Option (Right to Buy)	$5.33	A	6450	Acquired	2033-09-15	Common Stock (6450)	Direct

Footnotes

F1: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023.